UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Korea’s medical equipment industry too small in size, vulnerable'
Korea’s medical equipment industry lags far behind those of advanced countr...
by Nam Doo-hyun
|
2017-06-01 13:46
라인
Growth of ‘pharmerging market’ to increase demand for generic drugs
The growth of emerging pharmaceutical markets, including China and India, w...
by Nam Doo-hyun
|
2017-05-29 16:27
라인
Patent war looming over genome editing tech
The recent U.S. ruling regarding the patent dispute over the original techn...
by Nam Doo-hyun
|
2017-05-25 14:12
라인
Drugs halve death risks of uncomplicated hypertension patients
Continuous drug treatments can drastically reduce the mortality risks of pe...
by Nam Doo-hyun
|
2017-05-22 18:24
라인
Will Korea’s first stem cell therapy pass reexamination?
The pharmaceutical industry is following with interest whether Cellgram AMI...
by Nam Doo-hyun
|
2017-05-22 13:43
라인
No more calls for drug price hikes based on inaccurate statistics: MOHW
A pharmaceutical industry group has spread distorted information by repeate...
by Nam Doo-hyun
|
2017-05-19 15:13
라인
Young children of pharmaceutical firms’ owners have shares
Most pharmaceutical companies in Korea are run by owners’ families with the...
by Nam Doo-hyun
|
2017-05-17 17:18
라인
Government’s bio investment focuses on new drugs
The government has funneled about 10 percent of its fiscal spending on the ...
by Nam Doo-hyun
|
2017-05-12 13:55
라인
‘Korean pharmaceuticals should expand US export with new drugs’
With the United States stepping up protectionist measures, a state agency h...
by Nam Doo-hyun
|
2017-05-11 17:18
라인
Investors focus on Moon-related shares
The news of Moon Jae-in’s election victory is jolting the stock market, too...
by Nam Doo-hyun
|
2017-05-10 20:02
라인
JW Pharmaceutical worst of 10 major drugmakers for women to work in
In every election, presidential candidates have promised to shatter glass c...
by Nam Doo-hyun
|
2017-04-28 12:07
라인
How many Korean medical theses ranked in world’s top 1%
Korea has been ranked at the 15 place in the world by having about 3,600 me...
by Nam Doo-hyun
|
2017-04-19 18:42
라인
How to approach China's biopharmaceutical market
China’s biopharmaceutical market, sized at larger than 130 trillion won ($1...
by Nam Doo-hyun
|
2017-04-12 09:41
라인
Companies have to cooperate to develop ‘surgery robot’: KEIT
To target rapidly growing surgery robot market, domestic businesses need to...
by Nam Doo-hyun
|
2017-04-10 14:12
라인
Sanofi's Japanese encephalitis vaccine ad fuels fear
Pharmaceutical company Sanofi has come under fire for allegedly marketing i...
by Nam Doo-hyun
|
2017-04-04 17:30
라인
Exports of healthcare system remain in doldrums: Why?
Korea Medical Holdings (KMH), a public-private joint company founded to pro...
by Nam Doo-hyun
|
2017-04-03 14:33
라인
Sale of Remsima rises amid prescription growth in US, Europe
The sales of Remsima (Infliximab), Celltrion’s biosimilar for rheumatoid ar...
by Nam Doo-hyun
|
2017-03-30 15:43
라인
China delays merger of Canon and Toshiba Medical
The much-heralded merger of Canon and Toshiba Medical Systems is being dela...
by Nam Doo-hyun
|
2017-03-27 16:30
라인
Family-controlled drugmaker draws attention
Ilsung Pharmaceutical drew popular attention last year playing a role in th...
by Nam Doo-hyun
|
2017-03-24 11:20
라인
'Integrated operating room reduces surgical time, staffs'
The integration of operating room systems -- which controls various jobs do...
by Nam Doo-hyun
|
2017-03-23 11:24
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top